CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The HepaCute project focuses on developing biomarkers to predict the outcomes of acute hepatitis C infections. This research aims to improve patient management and reduce the health burden associated with chronic hepatitis C.
Chronic hepatitis C is one of the most common chronic viral infections of humans and a major cause of chronic liver disease, cirrhosis and liver cancer.
Still about 4 million new infections occur world-wide each year with 50-85% of patients progressing to chronic hepatitis C.
Currently there is no marker to predict spontaneous viral clearance and to guide treatment decisions.The major objectives of the HepaCute proposal are to develop biomarkers predicting the outcome of acute hepatitis C, impro…
KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, PARIS
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Germany, Hannover
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Freiburg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Parma
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
